Armata Pharmaceuticals, Inc. (ARMP)
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$173.8M
- Total assets
- $76.9M
- Market cap
- $275.3M
- Operating margin
- -747.0%
- Net margin
- -3544.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.9M
- Operating expenses
- $41.5M
- Operating income
- -$36.6M
- Net income
- -$173.8M
- EPS (basic)
- $-4.80
- EPS (diluted)
- $-4.80
Balance sheet
- Total assets
- $76.9M
- Current assets
- $10.7M
- Total liabilities
- $295.5M
- Current liabilities
- $8.9M
- Shareholders’ equity
- -$218.6M
Cash flow
- Operating cash flow
- -$25.8M
- Investing cash flow
- -$542.0K
- Financing cash flow
- $25.6M
- Net cash flow
- -$693.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $275.3M
- EPS (diluted)
- $-4.8
- Shares outstanding
- 59.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 27, 1994
Armata Pharmaceuticals, Inc. (ARMP) Stock Price
- Reported a net loss of $173.8M.
- Revenue grew 10% from FY2021 to FY2025.
- Trading 69% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Armata Pharmaceuticals, Inc..
Write a review
News about Armata Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Armata Pharmaceuticals, Inc.: frequently asked questions
Is Armata Pharmaceuticals, Inc. an American company?
Armata Pharmaceuticals, Inc. is a US-based company headquartered in Los Angeles, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Armata Pharmaceuticals, Inc. headquartered?
Armata Pharmaceuticals, Inc. is headquartered in Los Angeles, California, United States.
Is Armata Pharmaceuticals, Inc. publicly traded?
Yes — Armata Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARMP on the NYSE.
What does Armata Pharmaceuticals, Inc. do?
Armata Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
